-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

621.O1.6 621. Lymphomas: Translational – Molecular and Genetic: Insights into Lymphoma: Unraveling the Molecular Complexity for Precision Diagnostics and Therapeutics

Symposia: Lymphomas: Translational—Molecular and Genetic Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Translational Research, Lymphomas, non-Hodgkin lymphoma, genomics, bioinformatics, Diseases, Lymphoid Malignancies, Biological Processes, molecular biology, Technology and Procedures, profiling, Minimal Residual Disease , molecular testing, omics technologies
Monday, December 11, 2023: 2:45 PM-4:15 PM
Room 6DE (San Diego Convention Center)
Moderators:
Bertrand Nadel, PhD, Centre D'Immunologie De Marseille-Luminy and David W. Scott, MBChB, PhD, BC Cancer
Disclosures:
Scott: Janssen and Roche: Research Funding; Abbvie, AstraZeneca, Incyte: Consultancy.
2:45 PM

Andrew L. Feldman, MD1, Surendra Dasari, PhD2*, Lisa M. Rimsza, MD3, David W. Scott, MBChB, PhD4, Naoki Oishi5*, Catalina Amador, MD6*, Elias Campo, MD, PhD7, Wing C. Chan, MD8, James R. Cook, MD, PhD9, Jan Delabie, MD, PhD10*, Pedro Farinha, MD, PhD4, Kai Fu, MD, PhD11, Timothy C. Greiner, MS, MD12*, Giorgio Inghirami, MD13*, Javeed Iqbal, PhD, MSc12*, Elaine S. Jaffe, MD14, Sarah L. Ondrejka, DO9, German Ott, MD15*, Stefania Pittaluga, MD, PhD16*, Phil Raess, MD, PhD17*, Andreas Rosenwald, MD18*, Kerry J. Savage, MD, MSc, BSc19, Graham Slack, MD4*, Susan L. Slager, PhD2, Joo Y. Song, MD8, Louis M. Staudt, MD, PhD20, George Wright21*, Hao-Wei Wang, MD, PhD22*, Yu Zeng23*, Tadashi Yoshino, MD, PhD24*, Xiaojun Wu, MD, PhD25*, Ryan A. Wilcox, MD26, Xueju Wang27*, Akira Satou28*, Anamarija M. Perry, MD29, Roberto Miranda, MD30*, L. Jeffrey Medeiros, MD31, Matthew J. Maurer, DrMed2*, Eric Mou, MD32*, Young Hyeh Ko, MD33*, Kennosuke Karube, MD, PhD34*, Brad S. Kahl, MD35, Liuyan Jiang, MD36*, David L Jaye, MD37, Laurence de Leval, MD, PhD38, Weina Chen39*, Jennifer R. Chapman-Fredricks, MD6*, James R. Cerhan, MD, PhD2, Carlos Barrionuevo, MD40*, Stephen M Ansell, MD, PhD41 and Ahmed Aljudi, MD42*

1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
4BC Cancer, Vancouver, BC, Canada
5University of Yamanashi, Chuo, JPN
6Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL
7Hospital Clinic Provincial, Barcelona, ESP
8Beckman Research Institute, City of Hope, Duarte, CA
9Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH
10University of Toronto, Toronto, ON, CAN
11Department of Pathology & Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
12Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
13Weill Cornell Medicine, New York, NY
14CCR Lab of Pathology, National Cancer Institute, Bethesda, MD
15Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
16Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD
17Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR
18Institute of Pathology, Julius-Maximilians-Universität Würzburg, Wuerzburg, Germany
19Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada
20Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
21Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD
22Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
23Tongji Hospital, Tongji University School of Medicine, Shanghai, CHN
24Department of Pathology, Okayama University, Okayama, Japan
25Department of Pathology, Johns Hopkins Medicine, Baltimore, MD
26Division of Hematology/Oncology, University of Michigan Cancer Center, Ann Arbor, MI
27Jilin University, Changchun, CHN
28Aichi Medical University School of Medicine, Aichi, JPN
29Department of Pathology, University of Michigan, Ann Arbor, MI
30Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
31Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
32Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
33Department of Pathology, Korea University College of Medicine, Seoul, Korea, Republic of (South)
34Department of Pathology and Laboratory Medicine, Nagoya University, Nagoya, Japan
35School of Medicine, Washington University in St. Louis, St Louis, MO
36Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Jacksonville, FL
37Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA
38Hôpital Universitaire de Lausanne, Lausanne, Switzerland
39Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX
40Departamento de Patología, Instituto Nacional de Enfermedades Neoplásicas, Lima, PER
41Division of Hematology, Mayo Clinic, Rochester, MN
42Department of Pathology, Childrens Healthcare of Atlanta, Atlanta, GA

3:00 PM

Sabrina Baaklini, PhD1*, Alexandre Sarrabay1*, Camille Barthelemy1*, Laila Dahbi1*, Laurine Gil1*, Noushin Mossadegh-Keller, PhD1*, Jean-Marc Navarro1*, Caroline Huber1*, Romain Fenouil, PhD1*, Bertrand Escaliere1*, Romane Trombetta1*, Marine Pujol1*, Philippe Gaulard, MD2*, Benjamin Riviere, MD3*, Peggy Dartigues, MD4*, Francesco Llamas Gutierrez, MD5*, Celine Pangault6*, Fabrice Jardin, MD PhD7*, Francois Lemonnier8*, Gabriel Brisou9*, Corinne Haioun, MD, PhD10, Pauline Gravelle11*, Camille Laurent, MD, PhD12*, Lionel Spinelli, PhD1*, C Chris Huang, PhD13*, Matthew E Stokes13*, Sahil Seth13*, Maria Ortiz14*, Anita K. Gandhi, PhD14, Bertrand Nadel, PhD15,16, Pierre Milpied, PhD1* and Sandrine Roulland, PhD17*

1Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France
2Hôpital Henri Mondor, Créteil, France
3Pathology Department, Hôpital Gui De Chauliac, Montpellier, France
4Department of Pathology, Gustave Roussy, Villejuif, France
5Department of Pathology, CHU Pontchaillou, Rennes, France
6Pôle Biologie, CHU Rennes, Rennes, France
7Centre Henri-Becquerel and University of Rouen, Rouen, France
8Department of Hematology, Henri Mondor Hospital, Créteil, France
9Institut Paoli-Calmettes, Department of Hematology, Marseille Cedex 09, France
10Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
11INSERM UMR 1037-Cancer Research Center of Toulouse, TOULOUSE, France
12Pathology Department, Institut Universitaire du Cancer , Oncopole, Toulouse, France
13Bristol Myers Squibb, Summit, NJ
14Bristol Myers Squibb, Princeton, NJ
15Centre D'Immunologie De Marseille-Luminy, Marseilles, France
16Institut Carnot Calym, Lyon, France
17Centre d' Immunologie de Marseille - Luminy, Marseille, Cedex 09, France

3:15 PM

Natasha Lewis, MD1*, Kseniya Petrova-Drus, MD, PhD1,2*, Rohan Sardana, MD1*, Qi Gao, DCLS3*, Shenon Sethi, MBBS1*, Wenbin Xiao, MD, PhD1, Mikhail Roshal, MD, PhD3*, Jeeyeon Baik, BA, MPH1*, Himanshu Bhurtel, BS1*, Alison Moskowitz, MD4, Steven M. Horwitz, MD4 and Ahmet Dogan, MD, PhD1

1Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Pathology and Laboratory Medicine, Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan Kettering Cancer Center, New York
4Memorial Sloan Kettering Cancer Center, New York, NY

3:30 PM

James D Phelan, PhD1*, Sebastian Scheich, MD1*, Jaewoo Choi, PhD1, George Wright2*, Björn Häupl, PhD3*, Ryan M. Young, PhD1*, Sara Rieke4*, Martine Pape5*, Yanlong Ji, PhD6*, Henning Urlaub5*, Carmen Doebele7*, Alena Zindel4*, Tanja Wotapek5*, Monica Kasbekar, MD, PhD1, Da Wei Huang1*, Zana Coulibaly1*, Vivian M Morris8*, Xin Yu1*, Weihong Xu1*, Yandan Yang1*, Hong Zhao1*, Christopher J. Shoemaker9*, Zhuo Wang, PhD10*, Arthur Shaffer1*, Louis M. Staudt, MD, PhD1 and Thomas Oellerich, Prof. MD11*

1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD
3Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany
4Department of Hematology and Oncology, Unversity Hospital Frankfurt, Frankfurt, Frankfurt Am Main, DEU
5Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany
6Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany
73Department of Medicine II, Hematology/Oncology,, Goethe University, Frankfurt, Germany
8Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda
9Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH
10Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesday, MD
11German Cancer Consortium (DKTK), Partner site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany

3:45 PM

Alan Cooper1*, Sravya Tumuluru2*, Kyle Kissick3*, Girish Venkataraman3*, Joo Y Song, MD4*, Andrew Lytle5*, Gerben Duns, PhD6*, Jovian Yu, MD, MS1, Nikita Kotlov7*, Alexander Bagaev, PhD7*, Brendan Paul Hodkinson, PhD, BS8*, Srimathi Srinivasan9*, Sonali M. Smith1, David W. Scott, MBChB, PhD6, Christian Steidl, MD, PhD10, James Godfrey, MD11 and Justin Kline, MD1,2

1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
2Committee on Cancer Biology, University of Chicago, Chicago, IL
3Department of Pathology, University of Chicago, Chicago, IL
4Department of Pathology, City of Hope National Medical Center, Duarte, CA
5Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada
6BC Cancer, Vancouver, BC, Canada
7BostonGene, Corp., Waltham, MA
8Oncology Translational Research, Janssen Research & Development, Spring House, PA
9Oncology Translational Research, Janssen Research & Development, Lower Gwynedd Township, PA
10Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
11Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

4:00 PM

Alicia Beyou1*, Simon Leonard2*, Ilenia Papa2*, Noushin Mossadegh-Keller, PhD1*, Sabrina Baaklini, PhD1*, Lionel Spinelli, PhD1*, Owen Hoare1*, Bertrand Nadel, PhD3, Pierre Milpied, PhD1*, Joelle Dulong2*, Céline Monvoisin2*, Gabriel Brisou1*, Guillaume Cartron, MD, Ph-D4*, Karin Tarte, PhD, PharmD2* and Sandrine Roulland, PhD5*

1Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France
2Department of Immunology, Rennes University, CHU Rennes, UMR1236, Rennes, France
3Centre D'Immunologie De Marseille-Luminy, Marseilles, France
4IGMM UMR 5535 CNRS UM, University of Montpellier, Montpellier, France
5Centre d' Immunologie de Marseille - Luminy, Marseille, Cedex 09, France

*signifies non-member of ASH